Records whose title is actually about this topic. Use a country filter if the list is still too broad.
Records
Question· writtenPQ 1204asked
Ireland · Dáil Éireann · 19 May 2026
1204. Deputy Jen Cummins asked the Minister for Health the progress to date on Action 12 of the HSE Position Paper on FASD Prevention, published in September 2022 (details supplied); the specific measures undertaken to date; the current status of implementation; the timelines for any outstanding elements due to be completed within five years of publication; and if she will make a statement on the matter. [37623/26]
Question· writtenPQ 1198asked
Ireland · Dáil Éireann · 19 May 2026
1198. Deputy Liam Quaide asked the Minister for Health if she will confirm whether Action 5 of the HSE Position Paper (details supplied), which was due to be completed within three years of publication, has now been completed; and if she will make a statement on the matter. [37605/26]
Question· writtenPQ 1188asked
Ireland · Dáil Éireann · 19 May 2026
1188. Deputy Michael Collins asked the Minister for Health the amount of taxpayers' money that has been spent on training of healthcare workers with regard to abortion, on training of healthcare students with regard to abortion, on values clarifications courses with regard to abortion in each of the years from 2019 to date in 2026; and if she will make a statement on the matter. [37488/26]
Question· writtenPQ 1182asked
Ireland · Dáil Éireann · 19 May 2026
1182. Deputy Albert Dolan asked the Minister for Health the supports currently in place, aside from available tax reliefs, to assist individuals diagnosed with coeliac disease in managing the additional healthcare and dietary costs associated with the condition; whether consideration is being given to further supports, including eligibility for a GP visit card or medical card, for those living with coeliac disease; and if she will make a statement on the matter. [37444/26]
Question· writtenPQ 1166asked
Ireland · Dáil Éireann · 19 May 2026
1166. Deputy Marie Sherlock asked the Minister for Health the total number of public health nurses, by funded WTE and filled WTE; the number of public health nurses per community health network; the number of public health nurses per 10,000 of population; the number of public health nurses per integrated healthcare area from 2020 to end of 2025, in tabular form; and if she will make a statement on the matter. [37371/26]
Question· writtenPQ 1161asked
Ireland · Dáil Éireann · 19 May 2026
1161. Deputy Pádraig Rice asked the Minister for Health further to Parliamentary Question No. 257 of 3 December 2025, if the National Survey of the Experience of Home Support Workers and Nursing Home Healthcare Assistants has been completed; the date at which a final report of the Strategic Workforce Advisory Group on Home Carers and Nursing Home Health Care Assistants will be published; and if she will make a statement on the matter. [37305/26]
Question· writtenPQ 1159asked
Ireland · Dáil Éireann · 19 May 2026
1159. Deputy Eoin Hayes asked the Minister for Health her position on the management of vacant sites owned by the HSE and other public health organisations and how quickly they should be brought back into use, in particular the large sites at a location (details supplied). [37297/26]
Question· writtenPQ 1143asked
Ireland · Dáil Éireann · 19 May 2026
1143. Deputy Paul Murphy asked the Minister for Health if the National Clinical Programme for Gender Healthcare is on track to be fully delivered in July 2026, as recently mentioned at the Oireachtas Joint Committee on Health (details supplied). [37181/26]
Question· writtenPQ 1142asked
Ireland · Dáil Éireann · 19 May 2026
1142. Deputy Paul Murphy asked the Minister for Health for details of the significant work being done to stabilise existing trans healthcare services as recently mentioned at the Oireachtas Joint Committee on Health (details supplied). [37180/26]
Question· writtenPQ 1141asked
Ireland · Dáil Éireann · 19 May 2026
1141. Deputy Paul Murphy asked the Minister for Health to confirm that the National Clinical Programme for Gender Healthcare has trans healthcare falling under sexual health, as recently stated at the Oireachtas Joint Committee on Health (details supplied). [37179/26]
Question· writtenPQ 1128asked
Ireland · Dáil Éireann · 19 May 2026
1128. Deputy Barry Heneghan asked the Minister for Health whether she will support the introduction of free MART (ICS formoterol) inhalers for children aged 12 to 17 years (details supplied); and if she will make a statement on the matter. [37109/26]
Question· writtenPQ 1125asked
Ireland · Dáil Éireann · 19 May 2026
1125. Deputy Michael Cahill asked the Minister for Health to implement an assigned yearly budget for the implementation of the National Rare Disease strategy (details supplied); and if she will make a statement on the matter. [37094/26]
Question· writtenPQ 1123asked
Ireland · Dáil Éireann · 19 May 2026
1123. Deputy Ken O'Flynn asked the Minister for Health whether outcome monitoring or long-term follow-up arrangements exist for minors referred abroad for gender-related psychological services under the Treatment Abroad Scheme. [37081/26]
Question· writtenPQ 1122asked
Ireland · Dáil Éireann · 19 May 2026
1122. Deputy Ken O'Flynn asked the Minister for Health whether any national safeguarding framework specific to minors referred abroad for gender-related treatment currently exists. [37080/26]
Question· writtenPQ 1121asked
Ireland · Dáil Éireann · 19 May 2026
1121. Deputy Ken O'Flynn asked the Minister for Health whether the Department or HSE has assessed the long-term projected financial exposure associated with gender-related referrals abroad under the Treatment Abroad Scheme. [37079/26]
Question· writtenPQ 1120asked
Ireland · Dáil Éireann · 19 May 2026
1120. Deputy Ken O'Flynn asked the Minister for Health whether any external clinical guidelines, international protocols or evidence reviews were relied upon in approving gender-related referrals abroad for minors under the Treatment Abroad Scheme. [37078/26]
Question· writtenPQ 1119asked
Ireland · Dáil Éireann · 19 May 2026
1119. Deputy Ken O'Flynn asked the Minister for Health whether the HSE can provide the jurisdictions and healthcare providers to which paediatric gender-related referrals abroad were directed under the Treatment Abroad Scheme from 2020 to 2026. [37077/26]
Question· writtenPQ 1118asked
Ireland · Dáil Éireann · 19 May 2026
1118. Deputy Ken O'Flynn asked the Minister for Health whether any audit, value-for-money review, safeguarding review or clinical governance review has been conducted in respect of gender-related referrals abroad involving minors since 2020. [37076/26]
Question· writtenPQ 1112asked
Ireland · Dáil Éireann · 19 May 2026
1112. Deputy Ken O'Flynn asked the Minister for Health whether she will commit to publishing a national counselling services dashboard showing, by Health Region, referrals, re-referrals, unique clients, waiting times, sessions delivered, average sessions per client, outcomes and unmet demand. [37053/26]
Question· writtenPQ 1108asked
Ireland · Dáil Éireann · 19 May 2026
1108. Deputy Ken O'Flynn asked the Minister for Health whether any formal reconciliation report is produced comparing counselling activity data across Health Regions to identify anomalies, outliers, inconsistent definitions or unusual month-on-month movements; and if so, whether such reports will be published. [37049/26]
Question· writtenPQ 1102asked
Ireland · Dáil Éireann · 19 May 2026
1102. Deputy Michael Cahill asked the Minister for Health to urgently address issues raised in correspondence (details supplied) and ensure that the access to medicines for those with rare diseases will never be an issue for families; and if she will make a statement on the matter. [37032/26]
Question· writtenPQ 1100asked
Ireland · Dáil Éireann · 19 May 2026
1100. Deputy Ken O'Flynn asked the Minister for Health whether unannounced inspections are carried out in respect of private home support providers operating under HSE contracts. [37016/26]
Question· writtenPQ 1093asked
Ireland · Dáil Éireann · 19 May 2026
1093. Deputy Ken O'Flynn asked the Minister for Health whether any patient safety incidents, adverse event reviews, or governance concerns have been linked to duplicate, excessive, or delayed laboratory testing in primary care in the past five years; and if she will make a statement on the matter. [36998/26]
Question· writtenPQ 1092asked
Ireland · Dáil Éireann · 19 May 2026
1092. Deputy Ken O'Flynn asked the Minister for Health whether any national audit has been conducted examining variation in laboratory test ordering patterns between regions, GP practices, or primary care providers; and if she will make a statement on the matter. [36997/26]
Question· writtenPQ 1090asked
Ireland · Dáil Éireann · 19 May 2026
1090. Deputy Ken O'Flynn asked the Minister for Health the projected total cost of the National Laboratory Information System (MedLIS) rollout to completion in 2029; the expenditure incurred to date; and if she will make a statement on the matter. [36995/26]
Question· writtenPQ 1056asked
Ireland · Dáil Éireann · 19 May 2026
1056. Deputy Ken O'Flynn asked the Minister for Health whether the HSE has considered establishing a national centralised database of heavy metal exceedances in drinking water and associated public health advice. [36805/26]
Question· writtenPQ 1051asked
Ireland · Dáil Éireann · 19 May 2026
1051. Deputy Ken O'Flynn asked the Minister for Health whether the HSE has conducted any assessment of the potential public health risks associated with long-term exposure to manganese levels between 50 µg/l and 80 µg/l in drinking water. [36800/26]
Question· writtenPQ 1020asked
Ireland · Dáil Éireann · 19 May 2026
1020. Deputy Alan Kelly asked the Minister for Health the timeline for the creation of the new Limerick Hospital Development Board, which she said would be put in place following her announcement in March of a new hospital in Limerick for the mid-west region. [36720/26]
Question· writtenPQ 1016asked
Ireland · Dáil Éireann · 19 May 2026
1016. Deputy Ken O'Flynn asked the Minister for Health whether the Department has assessed the long-term economic impact of childhood obesity trends on future healthcare expenditure and labour-force participation. [36647/26]
Question· writtenPQ 1015asked
Ireland · Dáil Éireann · 19 May 2026
1015. Deputy Ken O'Flynn asked the Minister for Health whether obesity-related disease expenditure is separately identifiable within the HSE budgeting process; and if not, whether this has been identified as a strategic planning weakness. [36646/26]
Question· writtenPQ 1014asked
Ireland · Dáil Éireann · 19 May 2026
1014. Deputy Ken O'Flynn asked the Minister for Health whether any assessment has been carried out regarding the projected impact of obesity-related disease on future acute hospital capacity demand and workforce requirements to 2035. [36645/26]
Question· writtenPQ 1012asked
Ireland · Dáil Éireann · 19 May 2026
1012. Deputy Ken O'Flynn asked the Minister for Health whether the HSE centrally measures the proportion of hospital admissions attributable to obesity-related conditions; and if not, whether there are plans to introduce such measurement systems. [36643/26]
Question· writtenPQ 1011asked
Ireland · Dáil Éireann · 19 May 2026
1011. Deputy Ken O'Flynn asked the Minister for Health whether any national cost-of-illness study is currently underway regarding obesity-related disease expenditure across the health service; and if she will make a statement on the matter. [36642/26]
Question· writtenPQ 1010asked
Ireland · Dáil Éireann · 19 May 2026
1010. Deputy Ken O'Flynn asked the Minister for Health whether the HSE or her Department intends to introduce a formal national obesity-attributable disease modelling framework for Ireland; the proposed timeline for same; and if she will make a statement on the matter. [36641/26]
Question· writtenPQ 1004asked
Ireland · Dáil Éireann · 19 May 2026
1004. Deputy Ken O'Flynn asked the Minister for Health whether the updated Irish gender healthcare model of care will include a national audit framework, outcomes monitoring system, detransition support pathway, and safeguarding review mechanism for minors. [36609/26]
Question· writtenPQ 1003asked
Ireland · Dáil Éireann · 19 May 2026
1003. Deputy Ken O'Flynn asked the Minister for Health whether any Irish clinicians currently participate in multidisciplinary assessment processes connected to overseas gender-related healthcare referrals for minors. [36608/26]
Question· writtenPQ 1002asked
Ireland · Dáil Éireann · 19 May 2026
1002. Deputy Ken O'Flynn asked the Minister for Health the number of Irish minors currently awaiting referral, assessment, or treatment through overseas gender-related healthcare pathways supported by the Treatment Abroad Scheme. [36607/26]
Question· writtenPQ 1001asked
Ireland · Dáil Éireann · 19 May 2026
1001. Deputy Ken O'Flynn asked the Minister for Health whether the HSE has issued updated clinical guidance to GPs, consultant paediatricians, psychiatrists, or CAMHS teams concerning referrals of minors for gender-related healthcare abroad following changes introduced by the NHS in September 2024. [36606/26]
Question· writtenPQ 1000asked
Ireland · Dáil Éireann · 19 May 2026
1000. Deputy Ken O'Flynn asked the Minister for Health whether any pause, restriction, or revised clinical threshold was considered following publication of the Cass Review in relation to referrals of minors abroad for gender-related healthcare. [36605/26]
Question· writtenPQ 999asked
Ireland · Dáil Éireann · 19 May 2026
999. Deputy Ken O'Flynn asked the Minister for Health whether the HSE has conducted any assessment of the implications of the final Cass Review for Irish clinical practice regarding minors referred abroad for gender-related healthcare. [36604/26]
Question· writtenPQ 998asked
Ireland · Dáil Éireann · 19 May 2026
998. Deputy Ken O'Flynn asked the Minister for Health whether the HSE has undertaken any independent review of outcomes, safeguarding issues, regret rates, detransition rates, or long-term psychological outcomes associated with referrals of minors abroad for gender-related healthcare.; and if she will make a statement on the matter. [36603/26]
Question· writtenPQ 997asked
Ireland · Dáil Éireann · 19 May 2026
997. Deputy Ken O'Flynn asked the Minister for Health whether any formal written policy, clinical governance framework, or risk assessment governs referrals of minors abroad for gender-related healthcare; and if she will provide details. [36602/26]
Question· writtenPQ 996asked
Ireland · Dáil Éireann · 19 May 2026
996. Deputy Ken O'Flynn asked the Minister for Health the total expenditure incurred under the treatment abroad scheme in relation to referrals of minors for gender-related assessment or treatment abroad in each year since 2020. [36601/26]
Question· writtenPQ 986asked
Ireland · Dáil Éireann · 19 May 2026
986. Deputy Ken O'Flynn asked the Minister for Health whether the Health Service Executive has identified any jurisdictions with materially higher reimbursement costs under the treatment abroad scheme for equivalent procedures. [36584/26]
Question· writtenPQ 985asked
Ireland · Dáil Éireann · 19 May 2026
985. Deputy Ken O'Flynn asked the Minister for Health whether any maximum reimbursement thresholds, indicative cost bands, or comparative pricing references are used when assessing applications under the Treatment Abroad Scheme. [36583/26]
Question· writtenPQ 984asked
Ireland · Dáil Éireann · 19 May 2026
984. Deputy Ken O'Flynn asked the Minister for Health whether any internal audit, financial review, or governance assessment has examined variations in treatment abroad scheme reimbursement costs between jurisdictions for comparable procedures. [36582/26]
Question· writtenPQ 983asked
Ireland · Dáil Éireann · 19 May 2026
983. Deputy Ken O'Flynn asked the Minister for Health whether the Health Service Executive records the total reimbursement cost by treatment type and jurisdiction under the treatment abroad scheme. [36581/26]
Question· writtenPQ 982asked
Ireland · Dáil Éireann · 19 May 2026
982. Deputy Ken O'Flynn asked the Minister for Health whether any formal value-for-money methodology applies when approving treatment locations under the treatment abroad scheme. [36580/26]
Question· writtenPQ 981asked
Ireland · Dáil Éireann · 19 May 2026
981. Deputy Ken O'Flynn asked the Minister for Health whether any analysis has been carried out on whether equivalent procedures funded under the treatment abroad scheme could be accessed at lower cost in alternative jurisdictions within the EU, UK or Switzerland. [36579/26]
Question· writtenPQ 980asked
Ireland · Dáil Éireann · 19 May 2026
980. Deputy Ken O'Flynn asked the Minister for Health whether the HSE or her Department maintains any database, framework, or internal assessment comparing the average cost of treatments funded under the treatment abroad scheme across different jurisdictions. [36578/26]
PreviousPage 18 of 19Next